title: Incidence and management of primary malignant small bowel cancers: a well-defined French population study.
abstract: OBJECTIVE
  Few data are available from population-based statistics on small bowel cancers. The aim of this study was to report on their incidence and management.
  
  
  METHODS
  Data were obtained from the population-based Digestive Cancer Registry of Burgundy over a 26-yr period. Incidence rates were calculated by gender, age group, histological type, and 5-yr period. Treatment and stage at diagnosis were investigated. Prognosis was determined using crude and relative survival rates. A multivariate relative survival analysis was performed.
  
  
  RESULTS
  Age-standardized incidence rates were 1.2/100,000 inhabitants for men and 0.8/100,000 inhabitants for women. The mean 5-yr variation in incidence were, respectively, +46.7% (P < 0.01) and + 53.2% (P < 0.05). There were four main histological types: adenocarcinoma (40.4%), malignant endocrine tumors (30.5%), lymphoma (20.1%), and sarcoma (9.0%). Resection for cure was performed in 56.6% of the cases. Cancer was not extending beyond the organ in 33.2% of the cases, was associated with lymph node metastasis in 32.1%, and with distant metastasis or unresectability in 34.7%. The 5-yr relative survival rate was 37.4%. It varied between 56.8% for endocrine tumors and 17.8% for sarcoma. In the multivariate analysis, age, histology, and stage at diagnosis significantly influenced the prognosis.
  
  
  CONCLUSIONS
  Small bowel cancers represent a heterogeneous group of rare tumors. Prognosis at a population level is worse than in hospital series. In the short term, new therapeutic possibilities represent the best way to improve prognosis.
authors.affiliation: Faculté de médecine, Registre Bourguignon des Cancers Digestifs, INSERM EMI 0106, Dijon, France.
authors.forename: Côme
authors.initials: C
authors.lastname: Lepage
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Bouvier
authors.forename: Sylvain
authors.initials: S
authors.lastname: Manfredi
authors.forename: Vincent
authors.initials: V
authors.lastname: Dancourt
authors.forename: Jean
authors.initials: J
authors.lastname: Faivre
mesh_terms: D000230:Adenocarcinoma / Q000453:epidemiology* / Q000473:pathology / Q000628:therapy; D017677:Age Distribution; D000368:Aged; D004701:Endocrine Gland Neoplasms / Q000453:epidemiology* / Q000473:pathology / Q000628:therapy; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007414:Intestinal Neoplasms / Q000453:epidemiology* / Q000473:pathology / Q000628:therapy; D007421:Intestine, Small; D008223:Lymphoma / Q000453:epidemiology* / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012509:Sarcoma / Q000453:epidemiology* / Q000473:pathology / Q000628:therapy; D017678:Sex Distribution; D015996:Survival Rate